Literature DB >> 24636838

N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.

Shengen Yi1, Zhu-Lin Yang2, Xiongying Miao1, Qiong Zou3, Jinghe Li4, Lufeng Liang5, Guixiang Zeng6, Senlin Chen7.   

Abstract

Gallbladder cancer (GBC) is a rare, but highly aggressive cancer. The most common type of gallbladder cancer is adenocarcinoma (AC), while squamous cell/adenosquamous carcinoma (SC/ASC) is a rare type of gallbladder cancer. The clinicopathologic and biological characteristics of SC/ASC have not been well documented. In this study, the protein expression of N-cadherin and P-cadherin in 46 SC/ASCs and 80 ACs was measured using immunohistochemistry. We demonstrated that positive N-cadherin and P-cadherin expression were significantly associated with large tumor size, invasion, and lymph node metastasis of both SC/ASC and AC. In contrast, positive N-cadherin and P-cadherin expression were significantly associated with differentiation and TNM stage in only AC. Univariate Kaplan-Meier analysis showed that positive N-cadherin and P-cadherin expression, differentiation, tumor size, TNM stage, invasion, lymph node metastasis, and surgical curability were significantly associated with overall survival in both SC/ASC and AC patients. Multivariate Cox regression analysis showed that positive N-cadherin and P-cadherin expression are independent poor-prognostic factors in both SC/ASC and AC patients. Our study suggested that positive N-cadherin and P-cadherin expression closely correlated with clinicopathological and biological behaviors, and poor-prognosis of gallbladder cancer.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Adenosquamous carcinoma; Gallbladder cancer; Metastasis; N-cadherin; P-cadherin; Prognosis; Squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24636838     DOI: 10.1016/j.prp.2014.01.014

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

Review 1.  Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.

Authors:  Anitha K Shenoy; Jianrong Lu
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

Review 2.  Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.

Authors:  Tolutope Oyasiji; Jianliang Zhang; Boris Kuvshinoff; Renuka Iyer; Steven N Hochwald
Journal:  Oncologist       Date:  2015-05-29

Review 3.  Molecular Oncology of Gall Bladder Cancer.

Authors:  Arun Chaturvedi; Vijay Kumar; Sameer Gupta
Journal:  Indian J Surg Oncol       Date:  2019-11-16

Review 4.  Gallbladder Cancer in the 21st Century.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Shahid Ahmed; Selliah Chandra Kanthan
Journal:  J Oncol       Date:  2015-09-01       Impact factor: 4.375

Review 5.  P-cadherin and the journey to cancer metastasis.

Authors:  André Filipe Vieira; Joana Paredes
Journal:  Mol Cancer       Date:  2015-10-06       Impact factor: 27.401

Review 6.  Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks.

Authors:  Sunwang Xu; Ming Zhan; Jian Wang
Journal:  Cell Death Discov       Date:  2017-11-27

7.  Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.

Authors:  Sutthiwan Janthamala; Apinya Jusakul; Sarinya Kongpetch; Phongsaran Kimawaha; Poramate Klanrit; Watcharin Loilome; Nisana Namwat; Anchalee Techasen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-20       Impact factor: 3.000

8.  De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects.

Authors:  Andrea Accogli; Sara Calabretta; Judith St-Onge; Nassima Boudrahem-Addour; Alexandre Dionne-Laporte; Pascal Joset; Silvia Azzarello-Burri; Anita Rauch; Joel Krier; Elizabeth Fieg; Juan C Pallais; Allyn McConkie-Rosell; Marie McDonald; Sharon F Freedman; Jean-Baptiste Rivière; Joël Lafond-Lapalme; Brittany N Simpson; Robert J Hopkin; Aurélien Trimouille; Julien Van-Gils; Amber Begtrup; Kirsty McWalter; Heron Delphine; Boris Keren; David Genevieve; Emanuela Argilli; Elliott H Sherr; Mariasavina Severino; Guy A Rouleau; Patricia T Yam; Frédéric Charron; Myriam Srour
Journal:  Am J Hum Genet       Date:  2019-10-03       Impact factor: 11.043

9.  Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.

Authors:  Felix Royo; Patricia Zuñiga-Garcia; Verónica Torrano; Ana Loizaga; Pilar Sanchez-Mosquera; Aitziber Ugalde-Olano; Esperanza González; Ana R Cortazar; Laura Palomo; Sonia Fernández-Ruiz; Isabel Lacasa-Viscasillas; Maria Berdasco; James D Sutherland; Rosa Barrio; Amaia Zabala-Letona; Natalia Martín-Martín; Amaia Arruabarrena-Aristorena; Lorea Valcarcel-Jimenez; Alfredo Caro-Maldonado; Jorge Gonzalez-Tampan; Guido Cachi-Fuentes; Manel Esteller; Ana M Aransay; Miguel Unda; Juan M Falcón-Pérez; Arkaitz Carracedo
Journal:  Oncotarget       Date:  2016-02-09

10.  HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.

Authors:  Junyi He; Sheng Shen; Weiqi Lu; Yuhong Zhou; Yingyong Hou; Yong Zhang; Ying Jiang; Houbao Liu; Yebo Shao
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.